Previous studies demonstrate that specific A. muciniphila strains ameliorate colitis through multiple mechanisms: strain BAA-835 significantly improves acute colitis symptoms (36), other strains enhance retinoic acid synthesis and IL-22 production (37), and specific bacterial components regulate epithelial function through HDAC5-DAB2 signaling pathways (38). This evidence concerns the gene HDAC5 and colitis.